Canada markets closed

CytomX Therapeutics, Inc. (CTMX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.5000-0.6300 (-12.28%)
At close: 04:00PM EDT
4.6000 +0.10 (+2.22%)
After hours: 07:31PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 347.46M
Enterprise Value 186.93M
Trailing P/E N/A
Forward P/E 128.21
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.74
Price/Book (mrq)5.04
Enterprise Value/Revenue 1.85
Enterprise Value/EBITDA -43.38

Trading Information

Stock Price History

Beta (5Y Monthly) 1.02
52-Week Change 3207.19%
S&P500 52-Week Change 323.57%
52 Week High 35.8500
52 Week Low 31.0400
50-Day Moving Average 32.1220
200-Day Moving Average 31.6148

Share Statistics

Avg Vol (3 month) 34.32M
Avg Vol (10 day) 320.91M
Shares Outstanding 567.73M
Implied Shares Outstanding 667.73M
Float 853.83M
% Held by Insiders 11.19%
% Held by Institutions 148.51%
Shares Short (Apr 15, 2024) 43.59M
Short Ratio (Apr 15, 2024) 44.89
Short % of Float (Apr 15, 2024) 45.35%
Short % of Shares Outstanding (Apr 15, 2024) 45.31%
Shares Short (prior month Mar 15, 2024) 43.53M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -0.56%
Operating Margin (ttm)-2.28%

Management Effectiveness

Return on Assets (ttm)-1.75%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)101.21M
Revenue Per Share (ttm)1.37
Quarterly Revenue Growth (yoy)32.20%
Gross Profit (ttm)N/A
EBITDA -4.31M
Net Income Avi to Common (ttm)-569k
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)174.51M
Total Cash Per Share (mrq)2.58
Total Debt (mrq)13.97M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.17
Book Value Per Share (mrq)-0.70

Cash Flow Statement

Operating Cash Flow (ttm)-56.03M
Levered Free Cash Flow (ttm)43.66M